AKRO (Akero Therapeutics) Rega marang bathi mangsa ngarep

Lambang korporat lan logo Akero Therapeutics Inc (AKRO)

Akero Therapeutics (AKRO) is fighting for survival in a brutal biotech race where the risks of trial failure are extremely high. The potential for premium pricing will allow the company to dictate therapy costs in the future. The company's forward P/E ratio reflects the asset's value dynamics, with the value fixed at 0.00. Expectations for efruxifermin and its status as an attractive acquisition target for pharma behemoths are supporting the rise in share prices.

AKRO - Rasio prakiraan rega marang bathi Akero Therapeutics, Inc. ing rentang 04.07.2022 - 20.12.2025

Rincian analitis perusahaan Akero Therapeutics

Analisis umum perusahaan:AKRO akerotx.com
Produk merek Akero Corp

This indicator compares current market capitalization with expected net income, allowing for an assessment of the value of future earnings and preventing false conclusions drawn from one-off quarterly reports. For Akero Therapeutics (AKRO), whose value is based on the success of clinical trials for liver disease drugs, the company's forward P/E ratio history reflects the dynamics of market confidence in the potential of its scientific developments.

Pesaing Akero Therapeutics (AKRO)

Prakiraan rega marang bathi ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep corcept.com CORT|RYTM - Prakiraan rega marang bathi|Metsera Therapeutics - Pangali Forward P/E|Rasio prakiraan rega marang bathi MoonLake Pharma|CRNX (Crinetics) - Prakiraan rega marang bathi|NAMS: Rasio kapitalisasi marang bathi mangsa ngarep|SLNO (Soleno Therapeutics Corp) - Pangali Forward P/E|Pangali Forward P/E Amicus Therapeutics|Pangali Forward P/E ETNB|Rega marang bathi mangsa ngarep AGIO (Agios)|Rega marang bathi mangsa ngarep structuretx.com GPCR|MiMedx Corp (MDXG) - Rasio prakiraan rega marang bathi|RZLT - Rega marang bathi mangsa ngarep|LXRX: Rega marang bathi mangsa ngarep|MBX Biosciences, Inc. (MBX) - Rega marang bathi mangsa ngarep|ALT - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aardvark Pharma|Sagimet Biosciences Inc (SGMT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep bioagelabs.com (BIOA)|Prakiraan rega marang bathi Biomea Fusion, Inc. BMEA|Rega marang bathi mangsa ngarep Quince QNCX|GUTS (Fractyl Health Inc.) - Rasio rega marang bathi sing dikarepake|VTVT: Prakiraan rega marang bathi|Pangali forward rega marang bathi agapeatpgroup.com (ATPC)|PLUR (Pluri) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep SYBX|Rega marang bathi mangsa ngarep Lipocine Corporation|matinasbiopharma.com (MTNB) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SPRB|Prakiraan rega marang bathi Galecto, Inc. GLTO|Rega marang bathi mangsa ngarep Carmell Corporation CTCX|Pangali mangsa ngarep rega marang bathi LUMO|ONVO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RDUS (Radius Recycling Inc.)